Advances in Pharmacological Sciences
Volume 2018 (2018), Article ID 1718025, 4 pages
https://doi.org/10.1155/2018/1718025

Research Article

Investigation of Antioxidant/Oxidant Status and Antimicrobial Activities of Lentinus tigrinus

Mustafa Sevindik

Department of Biology, Faculty of Science, Akdeniz University, Antalya, Turkey

Correspondence should be addressed to Mustafa Sevindik; sevindik27@gmail.com

Received 11 August 2018; Revised 24 September 2018; Accepted 4 October 2018; Published 1 November 2018

Guest Editor: Azhar Rasul

Copyright © 2018 Mustafa Sevindik. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

In the present study, antioxidant and antimicrobial potential of the Lentinus tigrinus (Bull.) Fr. mushroom was determined. Total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) of the mushroom were measured with Rel Assay kits. Antimicrobial activities were tested on 9 standard bacterial and fungal strains (Staphylococcus aureus, Staphylococcus aureus MRSA, Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, Candida albicans, Candida krusei, and Candida glabrata) with a modified agar dilution method. It was determined that the TAS value of L. tigrinus was 1.748 ± 0.071, TOS value was 19.294 ± 0.237, and OSI was 1.106 ± 0.031. It was also found that mushroom extracts generally exhibited higher activity on Candida albicans, C. krusei, and C. glabrata. In conclusion, it was suggested that L. tigrinus can be used as a natural source due to its antioxidant and antimicrobial activities.

1. Introduction

Since historical times, several mushroom species have been consumed as nutrients and medicine of natural origin by humans [1]. Mushrooms can be considered as functional nutrients due to their health benefits and nutritional properties. In recent years, functional nutrients were again the center of focus for the consumers whose interest in human health, nutrition, and prevention from diseases has increased [2, 3]. Previous studies on mushrooms reported that mushrooms possessed several medical properties such as antioxidant, antimicrobial, DNA-protective, analgesic, anti-inflammatory, cytotoxic, antiviral, anticancer, antiparasitic, immunomodulation effects, and hepatoprotective activity [4–18]. The identification of medical potential of the mushrooms is significant for identification of new natural resources for fighting the diseases.

Lentinus tigrinus is a wood-rotting basidiomycete with leathery flesh, strong aroma, and taste that makes it applicable in gourmet preparations [19]. This basidiomycetous mushroom is often seen growing on fallen logs in the forest from May to September [20]. Previous studies reported that this mushroom contains high amounts of carbohydrates, proteins, fibers, and minerals [19].

The present study aimed at determining the total antioxidant status, total oxidant status, and oxidative stress index of L. tigrinus (Bull.) Fr. mushroom and the antimicrobial activities of the ethanol (EtOH), methanol (MeOH), and dichloromethane (DCM) extracts of the mushroom. This study will evaluate the availability of L. tigrinus mushroom for pharmacological designs.

2. Materials and Methods

2.1. Laboratory Studies

Lentinus tigrinus (Bull.) Fr. study samples were collected in Gaziantep province, Turkey. Morphological (shape, color, and size) and ecological characteristics of the samples were recorded in the field conditions. The microscopic characteristics of the specimens transported to the laboratory under appropriate conditions were determined by light microscopy using a 3% KOH solution (Leica DM750). The specimen was identified morphologically using the references of Käärik [21], Knudsen [22], Bresadola [23], Dähncke [24], Roux [25], and Boccardo et al. [26]. After the collected mushroom samples were identified, they were dried at 40°C in an incubator. Then, they were pulverized in a mechanical grinder. Then, pulverized 30 g mushroom samples were placed in cartridges, and the extracts were obtained with ethanol (EtOH) (Merck), methanol (MeOH) (Merck), and dichloromethane (DCM) (Merck) in a soxhlet extractor (Gerhardt EV) at 50°C for approximately 6 hours. The extracts were then concentrated under pressure at 40°C in a rotary evaporator (Heidolph Laborota 4000 Rotary Evaporator) to conduct the tests at +4°C [1].

2.2. Determination of Total Antioxidant Status (TAS), Total Oxidant Status (TOS), and Oxidative Stress Index (OSI)

The mushroom total antioxidant status (TAS), total oxidant status (TOS) levels, and oxidative stress index (OSI) were determined with Rel assay brand commercial kits (Rel Assay Kit Diagnostics, Turkey). Trolox was used as the calibrator in the TAS tests and hydrogen peroxide in the TOS tests [27, 28]. To determine the OSI, the mmol unit of TAS and the μmol unit of the TOS were cross-converted and the index value was expressed as percentage [28]. The TAS and TOS tests were conducted on 5 mushroom samples in 5 replicates.

2.3. Antimicrobial Activity Tests

Antimicrobial activity tests were conducted with the agar dilution method recommended by the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) on mushroom EtOH, MeOH, and DCM extracts. Minimal inhibitor concentration (MIC) for each extract was determined against standard bacterial and fungal strains. Staphylococcus aureus ATCC 29213, Staphylococcus aureus MRSA ATCC 43300, and Enterococcus faecalis ATCC 29212 were used as Gram-positive bacteria. Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Acinetobacter baumannii ATCC 19606 were used as Gram-negative bacteria. Candida albicans ATCC 10231, Candida krusei ATCC 34135 ATCC 13803, and Candida glabrata ATCC 90030 were used as fungi. Bacterial strains were precultured in Muller-Hinton Broth medium, and fungal strains were precultured in the RPMI 1640 broth medium. To obtain a standard inoculum, the turbidity of the bacteria and fungi was designed based on the McFarland 0.5 scale. All extracts were tested at concentrations of 800-12.5 μg/mL, and all dilutions were prepared with distilled water. Solvents used for the extraction were also tested for antimicrobial activity. Fluconazole and amphotericin B were used as reference drugs for the fungi and amikacin, and ampicillin and ciprofloxacin were used as reference drugs for the bacteria. The minimal dilution that inhibited the growth of bacteria and fungi was identified as the minimum inhibitory concentration (MIC) [29–34].

3. Results and Discussion

3.1. Total Antioxidant Status (TAS), Total Oxidant Status (TOS), and Oxidative Stress Index (OSI)

The mushroom TAS, TOS, and OSI values were determined with the Rel Assay kits. The findings demonstrated that the L. tigrinus TAS value was 1.748 ± 0.071, TOS value was 19.294 ± 0.237, and OSI was 1.106 ± 0.031. Mushrooms have the potential to contain several antioxidant enzymes and reduced coenzymes and reduced molecules such as phenolic compounds that include electron sources with the antioxidant effect. The analysis and evaluation of TAS as a marker of the system that reflects the whole of the enzymatic and nonenzymatic molecules that the fungi potentially produce and maintain are significant in identification and determination of new natural antioxidant sources. There are no previous studies that aimed at determining TAS, TOS, and OSI of L. tigrinus. In previous studies conducted with mushrooms on oxidative stress, it was determined that TAS values of Omphalotus olearius and Paxillus involutus were 2.827 and 1.230, TOS values were 14.210 and 7.533, and OSI values were 0.503 and 0.613, respectively [35, 36]. It was also reported that the TAS values of Helvella leucomelaena and Sarcosphaera coronaria were 2.367 and 1.066, TOS values were 55.346 and 41.662, and OSI values were 2.338 and 3.909, respectively [37]. In other studies, it was determined that the TAS value of Pleurotus eryngii was 1.93, and the TAS value of Auricularia polytricha was 0.93 [38, 39]. In the present study, it was observed that the TAS value of L. tigrinus used in this study was higher when compared to P. involutus, S. coronaria, and A. polytricha mushroom and lower when compared to O. olearius, H. leucomelaena, and P. eryngii. It was also observed that L. tigrinus TOS and OSI values were higher when compared to P. involutus and O. olearius and lower when compared to H. leucomelaena and S. coronaria. It was considered that the difference among the mushrooms was due to the variation in their capacity for reactive oxygen species production as a result of the environmental factors in fungal habitats. Thus, it is suggested that L. tigrinus had antioxidant potential; however, due to its high oxidant compound production capacity, the samples collected in Gaziantep province should not be consumed in excess. Furthermore, it was determined that samples collected in regions with adequate mushroom oxidative stress levels can be consumed as a natural antioxidant source.

3.2. Antimicrobial Activity

It was reported that mushrooms produce a variety of biologically active compounds, often associated with the cellular wall, and it was determined that several such compounds have biological activities. Indigenous communities considered mushrooms as potential sources of antibacterial drugs, and antibiotic research were initially started and succeeded with mushrooms [4, 40]. Thus, identification of fungal antimicrobial activities is very important for identification of the new antibacterial and antifungal agents. In the present study, EtOH, MeOH, and DCM extracts of L. tigrinus were evaluated against S. aureus, S. aureus MRSA, E. faecalis, E. coli, P. aeruginosa, A. baumannii, C. albicans, C. krusei, and C. glabrata. L. tigrinus extracts were compared with ampicillin, amikacin, ciprofloxacin, fluconazole, and amphotericin B which were used to treat general bacterial and fungal infections. In particular, L. tigrinus extracts showed antibacterial activity to different widths depending on the type of the infectious agent. The findings are presented in Table 1.

Table 1: Minimum inhibitory concentrations of different extracts of L. tigrinus and standard antibiotics against test microorganisms.

S. aureus
S. aureus MRSA
E. faecalis
E. coli
P. aeruginosa
A. baumannii
C. albicans
C. glabrata
C. krusei

EtOH
200
200
200
800
800
None
400
100
200

MeOH
200
400
200
None
None
None
800
200
200

DCM
800
800
800
None
None
None
800
400
400

Ampicillin
1.56
3.12
1.56
3.12
3.12
—
—
—
—

Amikacin
—
—
—
1.56
3.12
3.12
—
—
—

Ciprofloxacin
1.56
3.12
1.56
1.56
3.12
3.12
—
—
—

Fluconazole
—
—
—
—
—
—
3.12
3.12
—

Amphotericin B
—
—
—
—
—
—
3.12
3.12
3.12

The MIC values are presented in units of µg/mL.

Antimicrobial activity test findings demonstrated that EtOH extracts generally exhibited higher levels of activity on test microorganisms. Table 1 shows that the mushroom extracts were not effective on A. baumannii. Furthermore, mushroom EtOH extract exhibited activity against E. coli and P. aeruginosa, while MeOH and DCM extracts did not exhibit any activity in tested concentrations. It was found that the mushroom extracts were generally more active on fungal strains. Previous studies that were conducted to determine the antimicrobial activities of L. tigrinus reported that the acetonitrile extract was active against E. coli and S. aureus [20]. In a separate study, it was determined that water and n-hexane extracts of L. tigrinus were active against E. coli, Bacillus subtilis, B. licheniformis, S. aureus, and Agrobacterium tumefaciens in various concentrations [41]. Furthermore, it was determined that mushroom extracts were active on S. aureus, S. aureus MRSA, E. faecalis, C. albicans, C. glabrata, and C. krusei in concentrations of 100–800 μg/mL. In conclusion, it was determined that L. tigrinus can be consumed as a natural antimicrobial source against the microorganism that demonstrated the abovementioned activities. Mushrooms contain many compounds that show antimicrobial and antioxidant effects. In future, GC-MS studies can identify compounds in L. tigrinus. These compounds can be isolated and identified as compounds that cause antimicrobial and antioxidant effects. Crude extracts of L. tigrinus were used in our study. Antioxidant and antimicrobial potential of L. tigrinus was determined.

4. Conclusions

In the present study, total antioxidant status, total oxidant status, oxidative stress index, and antimicrobial potential of L. tigrinus were determined. It was determined that the mushroom possessed antioxidant potential as a result of the conducted analyses. However, it was recommended to limit the consumption of this mushroom due to high oxidant values. It was determined that L. tigrinus mushroom collected in regions with adequate oxidative stress levels may be consumed as a natural antioxidant source. Furthermore, the present study demonstrated that L. tigrinus may serve as a natural antimicrobial source against the microorganisms that exhibited activity in the tests conducted in the study.

Data Availability

No data were used to support this study.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

We would like to express our gratitude to Dr. Omer F. COLAK and Dr. Selami GUNAL for their contributions to the present study.

References

H. Akgul, M. Sevindik, C. Coban, H. Alli, and Z. Selamoglu, “New approaches in traditional and complementary alternative medicine practices: Auricularia auricula and Trametes versicolor,” Journal of Traditional Medicine and Clinical Naturopathy, vol. 6, no. 4, 2017.

P. Kalac, Edible Mushrooms, Chemical Composition and Nutritional Value, Academic Press, Cambridge, MA, USA, 1st edition, 2016.

C. I. Abuajah, A. C. Ogbonna, and C. M. Osuji, “Functional components and medicinal properties of food: a review,” Journal of Food Science and Technology, vol. 52, no. 5, pp. 2522–2529, 2015.

C. Ramesh and M. G. Pattar, “Antimicrobial properties, antioxidant activity and bioactive compounds from six wild edible mushrooms of western ghats of Karnataka, India,” Pharmacognosy Research, vol. 2, no. 2, p. 107, 2010.

G. Adotey, A. Quarcoo, J. C. Holliday, S. Fofie, and B. Saaka, “Effect of immunomodulating and antiviral agent of medicinal mushrooms (immune assist 24/7 TM) on CD4+ T-lymphocyte counts of HIV-infected patients,” International Journal of Medicinal Mushrooms, vol. 13, no. 2, pp. 109–113, 2011.

S. Patel and A. Goyal, “Recent developments in mushrooms as anti-cancer therapeutics: a review,” Biotech, vol. 2, no. 1, pp. 1–15, 2012.

V. Popovic, J. Zivkovic, S. Davidovic, M. Stevanovic, and D. Stojkovic, “Mycotherapy of cancer: an update on cytotoxic and antitumor activities of mushrooms, bioactive principles and molecular mechanisms of their action,” Current Topics in Medicinal Chemistry, vol. 13, no. 21, pp. 2791–2806, 2013.

A. A. Soares, A. B. De Sá-Nakanishi, A. Bracht et al., “Hepatoprotective effects of mushrooms,” Molecules, vol. 18, no. 7, pp. 7609–7630, 2013.

A. Ganeshpurkar and G. Rai, “Experimental evaluation of analgesic and anti-inflammatory potential of oyster mushroom Pleurotus Florida,” Indian Journal of Pharmacology, vol. 45, no. 1, p. 66, 2013.

E. A. Elsayed, H. El Enshasy, M. A. Wadaan, and R. Aziz, “Mushrooms: a potential natural source of anti-inflammatory compounds for medical applications,” Mediators of Inflammation, vol. 2014, Article ID 805841, 15 pages, 2014.

M. A. Haque, A. K. Sarker, R. K. Paul, S. S. Khan, and M. A. U. Islam, “Screening for antiparasitic activity of crude extracts of pleurotus highking, a Bangladeshi edible mushroom,” Bangladesh Pharmaceutical Journal, vol. 18, no. 1, pp. 38–41, 2015.

C. Bal, H. Akgul, M. Sevindik, I. Akata, and O. Yumrutas, “Determination of the anti-oxidative activities of six mushrooms,” Fresenius Environmental Bulletin, vol. 26, pp. 6246–6252, 2017.

A. Yilmaz, S. Yildiz, C. Kilic, and Z. Can, “Total phenolics, flavonoids, tannin contents and antioxidant properties of Pleurotus ostreatus cultivated on different wastes and sawdust,” International Journal of Secondary Metabolite (IJSM), vol. 4, no. 1, pp. 1–9, 2016.

T. A. Ajith and K. K. Janardhanan, “Indian medicinal mushrooms as a source of antioxidant and antitumor agents,” Journal of Clinical Biochemistry and Nutrition, vol. 40, no. 3, pp. 157–162, 2007.

N. J. Dubost, B. Ou, and R. B. Beelman, “Quantification of polyphenols and ergothioneine in cultivated mushrooms and correlation to total antioxidant capacity,” Food Chemistry, vol. 105, no. 2, pp. 727–735, 2007.

R. Sullivan, J. E. Smith, and N. J. Rowan, “Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine,” Perspectives in Biology and Medicine, vol. 49, no. 2, pp. 159–170, 2006.

P. Mattila, K. Suonpää, and V. Piironen, “Functional properties of edible mushrooms,” Nutrition, vol. 16, no. 7, pp. 694–696, 2000.

H. El-Enshasy, A. Daba, M. El-Demellawy, A. Ibrahim, S. El Sayed, and I. El-Badry, “Bioprocess development for large scale production of anticancer exo-polysaccharide by Pleurotus ostreatus in submerged culture,” Journal of Applied Sciences, vol. 10, no. 21, pp. 2523–2529, 2010.

R. M. R. Dulay, E. C. Cabrera, S. P. Kalaw, and R. G. Reyes, “Optimal growth conditions for basidiospore germination and morphogenesis of Philippine wild strain of Lentinus tigrinus (Bull.) Fr.,” Mycosphere, vol. 3, no. 6, pp. 926–933, 2012.

R. M. R. Dulay, L. A. Miranda, J. S. Malasaga, S. P. Kalaw, R. G. Reyes, and C. T. Hou, “Antioxidant and antibacterial activities of acetonitrile and hexane extracts of Lentinus tigrinus and Pleurotus djamour,” Biocatalysis and Agricultural Biotechnology, vol. 9, pp. 141–144, 2017.

A. Käärik, “Lentinus Fr.,” in Nordic Macromycetes, L. Hansen and H. Knudsen, Eds., vol. 2, p. 47, Nordswamp, Copenhagen, Denmark, 1992.

H. Knudsen, “Lentinus Fr.,” in Funga Nordica: Agaricoid, Boletoid and Cyphelloid Genera, H. Knudsen and J. Vesterholt, Eds., pp. 72-73, Nordswamp, Copenhagen, Denmark, 2008.

G. Bresadola, “Iconographia mycologica,” Società Botanica Italiana, Sezione Lombarda, vol. 11, pp. 509-510, 1929.

R. M. Dähncke, 1200 Pilze, Verlag, Aarau, Stuttgart, Germany, 2006, in German.

P. Roux, “Mille et un champignons,”, p. 1223, University of Iasi, Lasi, Romania, 2006, in French.

F. Boccardo, M. Traverso, A. Vizzini, and M. Zotti, Funghi d’ Italia, Zanichelli, Italia, 2008.

O. Erel, “A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation,” Clinical Biochemistry, vol. 37, no. 4, pp. 277–285, 2004.

O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–1111, 2005.

A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, “Antibiotic susceptibility testing by a standardized single disk method,” American Journal of Clinical Pathology, vol. 45, no. 4, pp. 493–96, 1966.

J. Hindler, L. Hochstein, and A. Howell, “Preparation of routine media and reagents used in antimicrobial susceptibility testing. Part 1. McFarland standards,” in Clinical Microbiology Procedures Handbook, H. D. Isenberg, Ed., American Society for Microbiology, Washington, DC, USA, 1992.

CLSI (The Clinical and Laboratory Standards Institute), Antimicrobial Susceptibility Testing of Anaerobic Bacteria, CLSI, Wayne, PA, USA, 8th edition, 2012.

EUCAST (European Committee on Antimicrobial Susceptibility Testing), Breakpoint Tables Fungal Isolate for Interpretation of MICs, EUCAST, Basel, Switzerland, 2014.

E. Matuschek, D. F. Brown, and G. Kahlmeter, “Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories,” Clinical Microbiology and Infection, vol. 20, no. 4, pp. 255–266, 2014.

EUCAST (European Committee on Antimicrobial Susceptibility Testing), Breakpoint Tables for Bacteria Interpretation of MICs and Zone Diameters, EUCAST, Basel, Switzerland, 2015.

M. Sevindik, H. Akgul, and C. Bal, “Determination of oxidative stress status of Ompholatus olearius gathered from adana and antalya provinces in Turkey,” SAÜ Fen Bilimleri Enstitüsü Dergisi, vol. 21, no. 3, pp. 324–327, 2017.

M. Sevindik, H. Akgul, A. I. Korkmaz, and I. Sen, “Antioxidant potantials of helvella leucomelaena and sarcosphaera coronaria,” Journal of Bacteriology and Mycology: Open Access, vol. 6, no. 2, Article ID 00173, 2018.

O. F. Çolak, A. Rasul, and M. Sevindik, “A study on Paxillus involutus: total antioxidant and oxidant potential,” Turkish Journal of Life Sciences, vol. 3, no. 2, pp. 244–247, 2018.

N. C. Yildirim, S. Turkoglu, N. Yildirim, and K. O. Ince, “Antioxidant properties of wild edible mushroom Pleurotus eryngii collected from Tunceli province of Turkey,” DJNB, vol. 7, no. 4, pp. 1647–1654, 2012.

E. Avci, G. Cagatay, G. A. Avci, S. C. Cevher, and M. Suicmez, “An edible mushroom with medicinal significance; Auricularia polytricha,” Hittite Journal of Science and Engineering, vol. 3, no. 2, pp. 111–116, 2016.

M. Kosanić, B. Ranković, and M. Dašić, “Mushrooms as possible antioxidant and antimicrobial agents,” Iranian Journal of Pharmaceutical Research: IJPR, vol. 11, no. 4, p. 1095, 2012.

G. Sadi, B. Emsen, A. Kaya, A. Kocabas, S. Cinar, and D. I. Kartal, “Cytotoxicity of some edible mushrooms extracts over liver hepatocellular carcinoma cells in conjunction with their antioxidant and antibacterial properties,” Pharmacognosy Magazine, vol. 11, no. 42, p. 6, 2015.